UY30743A1 - Nuevos analogos de pirazol, composiciones conteniéndolos, procedimientos de preparacion y aplicaciones - Google Patents
Nuevos analogos de pirazol, composiciones conteniéndolos, procedimientos de preparacion y aplicacionesInfo
- Publication number
- UY30743A1 UY30743A1 UY30743A UY30743A UY30743A1 UY 30743 A1 UY30743 A1 UY 30743A1 UY 30743 A UY30743 A UY 30743A UY 30743 A UY30743 A UY 30743A UY 30743 A1 UY30743 A1 UY 30743A1
- Authority
- UY
- Uruguay
- Prior art keywords
- compositions containing
- pirazol
- analogs
- applications
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La invencion se refiere a compuestos de formula (I) o una sal y solvato farmacéuticamente aceptables del mismo, en la que R1 es F o H y a procedimientos para su preparacion, a intermedios utilizados en su preparacion, a composiciones que los contienen y a usos de dichos compuestos. Los compuestos segun la presente invencion son utiles en numerosas enfermedades, trastornos y afecciones, en particular enfermedades, trastornos y afecciones alérgicos y respiratorios.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86733706P | 2006-11-27 | 2006-11-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY30743A1 true UY30743A1 (es) | 2008-07-03 |
Family
ID=39226772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY30743A UY30743A1 (es) | 2006-11-27 | 2007-11-26 | Nuevos analogos de pirazol, composiciones conteniéndolos, procedimientos de preparacion y aplicaciones |
Country Status (32)
Country | Link |
---|---|
US (1) | US7772269B2 (es) |
EP (1) | EP2097407A1 (es) |
JP (1) | JP4469924B2 (es) |
KR (1) | KR20090074264A (es) |
CN (1) | CN101541790A (es) |
AP (1) | AP2009004849A0 (es) |
AR (1) | AR063924A1 (es) |
AU (1) | AU2007327004A1 (es) |
BR (1) | BRPI0718672A2 (es) |
CA (1) | CA2667566C (es) |
CL (1) | CL2007003403A1 (es) |
CO (1) | CO6180447A2 (es) |
CR (1) | CR10745A (es) |
CU (1) | CU23801B7 (es) |
DO (1) | DOP2009000121A (es) |
EA (1) | EA016588B1 (es) |
EC (1) | ECSP099328A (es) |
GE (1) | GEP20125386B (es) |
GT (1) | GT200700104A (es) |
HN (1) | HN2007000505A (es) |
IL (1) | IL198412A0 (es) |
MA (1) | MA30924B1 (es) |
MX (1) | MX2009005526A (es) |
NO (1) | NO20092413L (es) |
NZ (1) | NZ576376A (es) |
PE (1) | PE20081299A1 (es) |
RS (1) | RS20090211A (es) |
TN (1) | TN2009000205A1 (es) |
TW (1) | TW200831495A (es) |
UA (1) | UA92833C2 (es) |
UY (1) | UY30743A1 (es) |
WO (1) | WO2008065493A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20100072090A (ko) | 2007-11-26 | 2010-06-29 | 화이자 인코포레이티드 | 5-lo 억제제로서의 피라졸 유도체 |
EP2151450A1 (de) * | 2008-07-29 | 2010-02-10 | Sandoz AG | Verfahren zur Aufarbeitung von mikrobiologisch hergestellten zyklischen Oligopeptiden |
EP2563359A1 (en) * | 2010-04-30 | 2013-03-06 | Allergan, Inc. | Novel treatment for age related macular degeneration and ocular ischemic disease associated with complement activation by targeting 5-lipoxygenase |
TWI527809B (zh) * | 2011-01-24 | 2016-04-01 | 百靈佳殷格翰國際股份有限公司 | 作為crth2拮抗劑之吡唑化合物 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE913866A1 (en) * | 1990-11-28 | 1992-06-03 | Ici Plc | Aryl derivatives |
CN1050840C (zh) | 1993-06-14 | 2000-03-29 | 美国辉瑞有限公司 | 咪唑脂氧合酶抑制剂 |
SK281577B6 (sk) * | 1994-10-18 | 2001-05-10 | Pfizer Inc. | Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze |
JP3400392B2 (ja) * | 1994-10-18 | 2003-04-28 | ファイザー製薬株式会社 | 5−リポキシゲナーゼ阻害剤及び新規医薬組成物 |
US5883106A (en) * | 1994-10-18 | 1999-03-16 | Pfizer Inc. | 5-lipoxygenase inhibitors |
WO1997011079A1 (en) | 1995-09-18 | 1997-03-27 | Pfizer Pharmaceuticals Inc. | Novel imidazole lipoxygenase inhibitors |
US6194585B1 (en) * | 1998-12-22 | 2001-02-27 | Pfizer Inc. | Process for preparing 5-lipoxygenase inhibitors |
JP2001100682A (ja) * | 1999-09-28 | 2001-04-13 | Sanyo Electric Co Ltd | サインシステム |
JP2001100686A (ja) * | 1999-09-28 | 2001-04-13 | Hitachi Kokusai Electric Inc | 表示データ取込方法及び比較検査装置 |
-
2007
- 2007-11-14 WO PCT/IB2007/003518 patent/WO2008065493A1/en active Application Filing
- 2007-11-14 AU AU2007327004A patent/AU2007327004A1/en not_active Abandoned
- 2007-11-14 CA CA2667566A patent/CA2667566C/en not_active Expired - Fee Related
- 2007-11-14 UA UAA200903927A patent/UA92833C2/ru unknown
- 2007-11-14 RS RSP-2009/0211A patent/RS20090211A/sr unknown
- 2007-11-14 EA EA200970422A patent/EA016588B1/ru not_active IP Right Cessation
- 2007-11-14 CN CNA2007800432018A patent/CN101541790A/zh active Pending
- 2007-11-14 MX MX2009005526A patent/MX2009005526A/es active IP Right Grant
- 2007-11-14 KR KR1020097010726A patent/KR20090074264A/ko not_active Application Discontinuation
- 2007-11-14 JP JP2009538801A patent/JP4469924B2/ja not_active Expired - Fee Related
- 2007-11-14 EP EP07848899A patent/EP2097407A1/en not_active Withdrawn
- 2007-11-14 GE GEAP200711271A patent/GEP20125386B/en unknown
- 2007-11-14 AP AP2009004849A patent/AP2009004849A0/xx unknown
- 2007-11-14 BR BRPI0718672-0A patent/BRPI0718672A2/pt not_active IP Right Cessation
- 2007-11-14 NZ NZ576376A patent/NZ576376A/en not_active IP Right Cessation
- 2007-11-23 AR ARP070105216A patent/AR063924A1/es not_active Application Discontinuation
- 2007-11-26 GT GT200700104A patent/GT200700104A/es unknown
- 2007-11-26 US US11/944,732 patent/US7772269B2/en not_active Expired - Fee Related
- 2007-11-26 UY UY30743A patent/UY30743A1/es not_active Application Discontinuation
- 2007-11-26 PE PE2007001660A patent/PE20081299A1/es not_active Application Discontinuation
- 2007-11-26 TW TW096144833A patent/TW200831495A/zh unknown
- 2007-11-26 HN HN2007000505A patent/HN2007000505A/es unknown
- 2007-11-27 CL CL200703403A patent/CL2007003403A1/es unknown
-
2009
- 2009-04-23 CR CR10745A patent/CR10745A/es not_active Application Discontinuation
- 2009-04-27 IL IL198412A patent/IL198412A0/en unknown
- 2009-05-13 EC EC2009009328A patent/ECSP099328A/es unknown
- 2009-05-15 CU CU20090083A patent/CU23801B7/es not_active IP Right Cessation
- 2009-05-20 CO CO09051941A patent/CO6180447A2/es not_active Application Discontinuation
- 2009-05-22 TN TNP2009000205A patent/TN2009000205A1/fr unknown
- 2009-05-26 DO DO2009000121A patent/DOP2009000121A/es unknown
- 2009-05-27 MA MA31925A patent/MA30924B1/fr unknown
- 2009-06-24 NO NO20092413A patent/NO20092413L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8622001A1 (es) | Derivados de sulfonamida para el tratamiento de enfermedades | |
CR10700A (es) | Derivados de sulfonamida | |
PA8627001A1 (es) | Compuestos para el tratamiento de enfermedades | |
ECSP066701A (es) | Derivados de sulfonamida para el tratamiento de enfermedades | |
PA8632801A1 (es) | Derivados de tetrahidronaftiridina | |
AR069490A1 (es) | Agonistas de los receptores de glucocorticoides | |
ECSP088717A (es) | Derivados de amina | |
CR8649A (es) | Derivados de formamidina para el tratamiento de enfermedades | |
GT200400116A (es) | Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades. | |
ECSP066975A (es) | Derivados de fenol y tiofenol 3-o 4-monosustituidos utiles como ligandos de h3 | |
CR8636A (es) | Compuestos utiles para el tratamiento de enfermedades | |
PA8603001A1 (es) | Compuestos utiles para el tratamiento de enfermedades | |
UY30743A1 (es) | Nuevos analogos de pirazol, composiciones conteniéndolos, procedimientos de preparacion y aplicaciones | |
SV2005002056A (es) | Derivados de formamida para el tratamiento de enfermedades ref. pc32168a | |
GT200500056A (es) | Compuestos utiles para el tratamiento de enfermedades | |
CU20060180A7 (es) | Derivados de formamida para el tratamiento de enfermedades | |
DOP2005000043A (es) | Compuestos para el tratamiento de enfermedades | |
ECSP066700A (es) | Derivados de sulfonamida para el tratamiento de enfermedades | |
CU23532B7 (es) | Derivados de sulfonamida para el tratamiento de enfermedades | |
CU23537B7 (es) | Derivados de sulfonamida para el tratamiento de enfermedades | |
CR8514A (es) | Derivados de sulfonamida para el tratamiento de enfermedades | |
ECSP066832A (es) | Compuestos para el tratamiento de enfermedades | |
CR8513A (es) | Derivados de sulfonamida para el tratamiento de enfermedades | |
DOP2005000037A (es) | Compuestos utiles para el tratamiento de enfermedades | |
ECSP066871A (es) | Derivados de formamida útiles como adrenoceptores |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20170802 |